Related Experiment Video
Updated: May 29, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Therapeutic options in cutaneous melanoma: latest developments.
Rodabe N Amaria1, Karl D Lewis, Rene Gonzalez
1Department of Hematology/Oncology, University of Colorado at Denver, Aurora, Colorado, USA.
Therapeutic Advances in Medical Oncology
|September 30, 2011
Summary
New melanoma treatments, including ipilimumab and BRAF pathway inhibitors, offer hope for advanced disease. These therapies enhance the immune system or target specific mutations, improving patient survival and marking a new era in melanoma management.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Melanoma is often fatal in advanced stages due to resistance to traditional therapies.
- Recent advances in understanding melanoma tumorigenesis have paved the way for novel treatments.
- Targeted therapies and immunotherapies are showing significant promise.
Purpose of the Study:
- To review recent progress in treating advanced melanoma.
- To highlight novel targeted therapies and immunotherapies.
- To discuss the impact of new treatments on patient outcomes.
Main Methods:
- Review of recent clinical trials and scientific literature.
- Focus on immunotherapies like ipilimumab (monoclonal antibody).
- Examination of targeted therapies for BRAF mutations (mitogen-activated protein kinase pathway).
Main Results:
- Ipilimumab (monoclonal antibody) is FDA-approved for unresectable melanoma, demonstrating improved overall survival.
- Targeting the BRAF pathway shows impressive responses in patients with specific mutations.
- These advancements represent a paradigm shift in melanoma treatment.
Conclusions:
- A new era in advanced melanoma management has begun.
- Novel targeted therapies and immunotherapies are significantly improving outcomes.
- Continued research into melanoma tumorigenesis will drive further therapeutic innovation.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...